FDA Inspection 1291258 — Robyn D. Siperstein, M.D.
The FDA completed an inspection of Robyn D. Siperstein, M.D. on November 5, 2025 in Boynton Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 5, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Boynton Beach, FL (United States)
Additional Details
Clinical Investigator (CI)